Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02374827 · ClinicalTrials.gov registry record · NA
Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02374827: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02374827 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02374827, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
To compare the feasibility and surgical outcomes between complete salpingectomy and standard postpartum tubal ligation (partial salpingectomy) at the time of cesarean delivery in women with undesired future fertility. as a possible ovarian cancer risk-reducing procedure.
Primary Outcome
The primary outcome will involve measuring the amount of surgical time required to complete the assigned sterilization procedure
Interventions
- PROCEDURE Standard postpartum tubal ligation
- PROCEDURE Complete Salpingectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02374827 record still lists
NCT02374827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard postpartum tubal ligation is the first listed.
NCT02374827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02374827 about?
NCT02374827 is a clinical study titled "Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)". To compare the feasibility and surgical outcomes between complete salpingectomy and standard postpartum tubal ligation (partial salpingectomy) at the time of cesarean delivery in women with undesired future fertility. as a possible ovarian cancer risk-reducing procedure.
What is the current status of trial NCT02374827?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-04. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02374827?
The interventions under investigation include: Standard postpartum tubal ligation (PROCEDURE), Complete Salpingectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02374827?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02374827's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia